Browsing: could

Data from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA), specifically its Yellow Card Biobank, suggests that GLP-1s are not only linked to deaths but thousands of instances of other, less serious symptoms, such as gastrointestinal issues and nervous system disorders